SCHEMBL1645647

SCHEMBL1645647

COCOc1ccc([N+](=O)[O-])c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2)c1

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.80
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645651 1.00 BACE1 (0.80) BACE1MAPT
SCHEMBL1646884 0.89 BACE1 (1.00) BACE1MAPT
SCHEMBL1646886 0.89 BACE1 (1.00) BACE1MAPT
SCHEMBL1646226 0.87 BACE1 (0.82) BACE1MAPT
SCHEMBL1646231 0.87 BACE1 (0.82) BACE1MAPT
SCHEMBL1648440 0.84 BACE1 (1.00) BACE1
SCHEMBL1648443 0.84 BACE1 (1.00) BACE1
SCHEMBL1647362 0.84 BACE1 (0.71) BACE1
SCHEMBL1647359 0.84 BACE1 (0.71) BACE1
SCHEMBL1647006 0.83 BACE1 (1.00) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed